Clinical Trial: A multicenter prospective cohort study on the progression from allergic rhinitis to asthma (CARAS) in patients across different age groups and the construction of an AI-based prediction model. (China)

Posted On: 2026-09-29

China, Sept. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter prospective cohort study on the progression from allergic rhinitis to asthma (CARAS) in patients across different age groups and the construction of an AI-based prediction model.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133491

Registration Time: 2026/09/28

Type: Observational study

Primary Sponsor: The second affiliated hospital of Zhejiang University school of medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335389

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A multicenter prospective cohort study on the progression from allergic rhinitis to asthma (CARAS) in patients across different age groups and the construction of an AI-based prediction model. (China)